Related Experiment Video
Updated: Jan 14, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
NTCP Modeling of Visual Processing Speed Impairment and Related Factors Following Radiotherapy in Patients with Brain
Zahra Roozmand1, Mohammad Ali Boroomand2, Farzan Madadizadeh3
1Department of Medical Physics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
This study developed a model to predict visual processing speed (VPS) impairment after whole-brain radiotherapy. Keeping hippocampal radiation doses below 20 Gy may reduce normal tissue complication probability to under 25%.
Area of Science:
- Radiation Oncology
- Neuro-oncology
- Medical Physics
Background:
- Brain metastases frequently cause neurocognitive deficits, including impaired visual processing speed (VPS).
- Whole-brain radiotherapy (WBRT) is a common treatment for brain metastases.
- Assessing the risk of VPS impairment is crucial for optimizing WBRT.
Purpose of the Study:
- To develop a Normal Tissue Complication Probability (NTCP) model for VPS impairment after WBRT.
- To identify dosimetric and clinical predictors of VPS impairment.
- To provide a tool for predicting and potentially mitigating radiation-induced neurotoxicity.
Main Methods:
- Retrospective analysis of 18 patients treated with WBRT.
- Hippocampal dose-volume histograms (DVHs) were generated.
- NTCP models were calculated using the Lyman model and multivariable logistic regression.
Main Results:
- Visual processing speed (VPS) impairment was observed in 33.3% of patients.
- The Lyman-Kutcher-Burman (LKB) model yielded TD50 of 38.43 Gy.
- Multivariable logistic regression demonstrated superior predictive performance over the Lyman model, though no specific variables were significant predictors (P > 0.05).
Conclusions:
- A predictive model for radiation-induced visual processing speed (VPS) impairment was successfully developed.
- The study suggests that limiting hippocampal radiation dose to under 20 Gy could maintain Normal Tissue Complication Probability (NTCP) below 25%.
- Further research with larger cohorts is warranted to validate these findings and refine predictive models.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
06:44Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020